Dr. Timo Schürg

Selbstständig, Independent Consultant - Strain Engineering and Bioprocess Development, Self-employed

Berkeley, Vereinigte Staaten

Fähigkeiten und Kenntnisse

Breites Wissen und Erfahrungen in den Bereichen fi
Bioprozesstechnik
Fermentation
Proteinexpression
Strain engineering
Hefe
Mikrobiologie
Molekularbiologie
Biochemie
Zellbiologie
Phytopathologie
Biotechnologie. Starke internationale Vernetzung i
qRT-PCR
TAIL-PCR
Yeast recombinational cloning
Southern-
Northern-
and Western analysis
In-gel catalase activity assay
first experiences with cDNA-Microarrays. +++ imagi
deconvolution microscopy
Laser scanning microscopy (Zeiss LSM Meta 510)
FRAP
first experiences with FRET
2-photon-
4Pi- and TIRF- microscopy. +++ microbiology: well
yeast and other microorganisms. +++ Plant biotechn
glucuronidase and gfp reporter assays. +++ IT: wel
Origin (data analysis)
DNASTAR Lasergene
Vector NTI
SVI Huygens Deconvolution
ImageJ
Adobe Photoshop

Werdegang

Berufserfahrung von Timo Schürg

  • Bis heute 7 Jahre und 2 Monate, seit März 2017

    Independent Consultant - Strain Engineering and Bioprocess Development

    Self-employed

    Microbial strain engineering and bioprocess development consulting services for biotech start-up businesses (currently Perfect Day, Inc.)

  • 2 Jahre und 7 Monate, Juni 2018 - Dez. 2020

    Scientist III - Lead of Strain Engineering

    Perfect Day, Inc.

    Engineering microbes for industrial production of dairy proteins

  • 1 Jahr und 1 Monat, Mai 2017 - Mai 2018

    Scientist III - Lead of Fungal Biology and Bioprocessing

    Perfect Day, Inc.

    Develop fungal platforms for industrial production of dairy proteins

  • 2 Jahre und 2 Monate, Apr. 2015 - Mai 2017

    Postdoc

    Joint BioEnergy Institute (JBEI), Lawrence Berkeley National Laboratory

    Enzymproduktion fuer die Herstellung von Biokraftstoffen - Gentechnik / Produktions-Stamm Optimisierung • develop a fungal production platform with enhanced secreted cellulase enzyme titers using systems biology tools, rational strain design and genetic engineering • establish mutagenesis and screening protocols to generate high performance cellulase expression hosts • optimize fermentation conditions for filamentous fungi for high-yield enzyme production • train and supervise research assistants

  • 3 Jahre, Apr. 2012 - März 2015

    Postdoc

    Energy Biosciences Institute at UC Berkeley, CA, USA

    Forschung: Bioengineering, Biofuels, Aufschluss von Biomasse, fungal secretion. Principal Investigator: Prof. Louise Glass, University of California, Berkeley

  • 4 Jahre und 6 Monate, Okt. 2007 - März 2012

    PhD student

    TU Braunschweig

    AG Prof. Dr. A. Fleißner, "Intercellular Communication during Cell Fusion in Neurospora crassa"

  • 6 Monate, Apr. 2007 - Sep. 2007

    Wissenschaftlicher Mitarbeiter

    WWU Münster

    AG Prof. Dr. P. Tudzynski, "Reactive Oxygen Biology in Host-pathogen Interactions"

  • 3 Monate, Juli 2004 - Sep. 2004

    Praktikant

    BASF Plant Science GmbH

  • 2 Monate, Juni 1997 - Juli 1997

    Praktikant

    GBF, heute: Helmholtz Zentrum für Infektionsforschung

Ausbildung von Timo Schürg

  • Bis heute

    Biologie

    TU Braunschweig

    Zellbiologie, Molekularbiologie

  • UC Berkeley, USA

    Zellbiologie

  • Biologie

    WWU Münster

    Biochemie, Mikrobiologie, Molekularbiologie der Pilze, Phytopathologie

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Spanisch

    Fließend

  • Französisch

    Grundlagen

  • Arabisch

    Grundlagen

Interessen

industrial biotechnology
bioenergy
synthetic building blocks (biogenic)
metabolic engineering
synthetic biology
sustainability
greentelligence
protein engineering
filamentous fungi
yeast
phytopathology
plant biotechnology
protein purification
heterologous protein production
recombinant technologies +++ business development
business intelligence
strategic marketing +++ cellular signaling
exocytosis
secretion
cell-cell fusion
cell polarity
directed growth
biochemistry
pharmacological research
immunotherapy
protein design
drug safety
neurobiology
live-cell imaging

21 Mio. XING Mitglieder, von A bis Z